[Polaprezinc].
Kuwayama
Hajime
H
Department of Gastroenterology and Hepatology, Koshigaya Hospital, Dokkyo University School of Medicine.
Takahashi
Morio
M
Suzuki
Kazuyoshi
K
Suga
Mariko
M
Takata
Hironobu
H
Ohara
Taro
T
Koizumi
Kazuto
K
Kiriyama
Yuji
Y
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000658:Amoxicillin / Q000627:therapeutic use; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use; D002336:Carnosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D024881:Drug Resistance, Bacterial; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D064747:Lansoprazole; D008795:Metronidazole / Q000627:therapeutic use; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000494:pharmacology / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy / Q000209:etiology; D014510:Urease / Q000037:antagonists & inhibitors; D017967:Zinc Compounds
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D017967:Zinc Compounds; D064747:Lansoprazole; C061957:polaprezinc; D008795:Metronidazole; D000658:Amoxicillin; D002336:Carnosine; D014510:Urease; D017291:Clarithromycin; D009853:Omeprazole